CUA Highlights of GU ASCO 2022 - Kidney Cancer Session
Canadian Urological Association (CUA)
English - February 22, 2022 05:00 - 49 minutes - 45.3 MBMedicine Health & Fitness Science Life Sciences medicine urologic urology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Disclosures:
Anil Kapoor
Advisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-Zeneca
Speakers Bureau: Merck, Ipsen, Eisai
Investments: Verity, Point Biopharma
Clinical Trials: CCTG, Eisai, Janssen, Merck
Leadership/Board Position
Christian Kollmannsberger
Consultant: Pfizer, Merck, Sanofi, Astellas, BMS, Ipsen, Eisai, Bayer
Honoraria for presentations: Pfizer, Ipsen, Eisai, BMS, Janssen, Bayer
Scientific Advisory Board: Pfizer, Novartis, Ipsen, Eisai, Sanofi, Astellas, BMS, Janssen, Bayer, Merck